Connect with us

Technology

Lion Global Investors Launches Singapore’s First Actively Managed ETF in Collaboration with Nomura Asset Management

Published

on

The Lion-Nomura Japan Active ETF (Powered by AI) will be Singapore’s first active ETF on the Singapore Exchange and Singapore’s first AI-powered ETF. It has three key features:

Actively Managed: Focuses on 50-100 Japanese companies with high capital appreciation potential[1].Intelligent: Lion Global Investors’ and Nomura Asset Management’s proprietary AI models work faster than humans and can evaluate hundreds of factors for securities selection.Dynamic: AI models are refreshed monthly, enabling them to respond to trends dynamically.

SINGAPORE, Jan. 12, 2024 /PRNewswire/ — Lion Global Investors (LGI) today announced the launch of Singapore’s first actively managed ETF, in collaboration with Nomura Asset Management group (NAM), the Lion-Nomura Japan Active ETF (Powered by AI). It is Singapore’s first active ETF and also its first AI-powered one.

 

The Lion-Nomura Japan Active ETF (Powered by AI) offers clients exposure to the Japan stock market through an actively managed portfolio of 50-100 securities listed in Japan. It seeks to provide long-term capital growth by investing primarily based on results from LGI’s and NAM’s proprietary artificial intelligence (AI) and machine learning models that look at fundamental, technical, qualitative and quantitative analyses.

Teo Joo Wah, CEO, Lion Global Investors said that the launch of the Lion-Nomura Japan Active ETF (Powered by AI) and LGI’s expansion into the active ETF space underscores the firm’s mission to align to clients’ desire for cost-effective solutions that are actively managed and nimble for more efficient portfolio management, especially in today’s evolving macroeconomic environment.

 “Expanding our offerings to include active ETFs represents our response to evolving investor demand and our commitment to broadening access to LGI’s strategies. The launch of our first active ETF on a Japan-focused theme using AI models in collaboration with Nomura Asset Management reflects our joint commitment to deliver efficient investment solutions to investors in Singapore.” 

With retail investors showing a greater appetite for ETF investing since 2019, it is a strategic move by Singapore Exchange (SGX Group) to embark on the listing of Active ETFs in 2024 to harness the growth potential of this thriving ETF environment.

“SGX Group congratulates Lion Global Investors and Nomura Asset Management on pioneering Singapore’s first active ETF. This marks a new milestone in our expanding ETF shelf, showcasing product innovation and diversity for increased investor adoption in the ETF ecosystem. By leveraging AI, this active ETF adopts a dynamic approach, enabling the investment managers to respond to market changes through more frequent portfolio re-balancing. This launch also presents a timely opportunity for investors to capitalise on the resurgence of interest in the Japanese stock market,” said Janice Kan, Co-Head of Equities, SGX Group.

Providing investors easy access to Japan

Teo added that AI and Japan are themes that investors have shown strong interest in recent times. “AI is a capability that LGI has been developing since 2019. The Japanese market is supported by several tailwinds such as corporate governance reforms and strong foreign investor interest, which we expect to continue to drive momentum.  We are therefore excited to offer clients a new strategy that can help them access Japan via an actively managed ETF. We are happy that this collaboration will allow Singapore investors to benefit from NAM’s deep experience and knowledge of Japan and AI.”

Takahiro Kawabe, Managing Director and CEO, Nomura Asset Management Singapore Limited, said, “The Lion-Nomura Japan Active ETF (Powered by AI) leverages on NAM’s legacy of 65 years of leadership and experience investing in Japanese companies while offering the additional benefits of an active ETF structure including market access to Japan, nimble portfolio management and better risk management. While we are a leader in Japan ETFs and have recently launched our first two active ETFs there, this is our first for Singapore in collaboration with LGI.” 

Initial Offering Period 

The Initial Offering Period (IOP) of the Lion-Nomura Japan Active ETF (Powered by AI) is from January 5 to 25, 2024. It lists on the Singapore Exchange (SGX) on January 31, 2024 and will be available in both Singapore and US dollar denominations under the SGX code JJJ and JUS respectively. The issue price of each unit during the IOP is SGD 1.00.

During the IOP, investors may subscribe to the ETF through OCBC ATMs/internet banking/mobile banking and participating dealers including iFAST Financial Pte. Ltd., Moomoo Financial Singapore Pte. Ltd., OCBC Securities Pte. Ltd., Phillip Securities Pte. Ltd. and Tiger Brokers (Singapore) Pte. Ltd.

Disclaimer – Lion Global Investors Limited

This advertisement or publication has not been reviewed by the Monetary Authority of Singapore. It is for information only, and is not a recommendation, offer or solicitation to deal in any capital markets products or investments and does not have regard to your specific investment objectives, financial situation, tax position or particular needs.

You should read the Prospectus and Product Highlights Sheet for the Lion-Nomura Japan Active ETF (Powered by AI) (“ETF”) which are available and may be obtained from Lion Global Investors Limited (“LGI”) or any of the appointed Participating Dealers (“PDs”), for further details including the risk factors and consider if the ETF is suitable for you and seek such advice from a financial adviser if necessary, before deciding whether to purchase units in the ETF. Investments in the ETF are not obligations of, deposits in, guaranteed or insured by LGI or any of its affiliates and are subject to investment risks including the possible loss of the principal amount invested. The ETF is an actively managed exchange traded fund. Please refer to the Prospectus for further details, including a discussion of certain factors to be considered in connection with an investment in an actively managed exchange traded fund.

The performance of the ETF, the value of its units and any accruing income are not guaranteed and may rise or fall. Past performance, payout yields and payments and any predictions, projections, or forecasts are not indicative of the future or likely performance, payout yields and payments of the ETF. Any extraordinary performance may be due to exceptional circumstances which may not be sustainable. Any dividend distributions, which may be either out of income and/or capital, are not guaranteed and subject to the manager of the ETF’s discretion. Any such dividend distributions will reduce the available capital for reinvestment and may result in an immediate decrease in the net asset value of the ETF. Any references to specific securities are for illustration purposes and are not to be considered as recommendations to buy or sell the securities. It should not be assumed that investment in such specific securities will be profitable. There can be no assurance that any of the allocations or holdings presented will remain in the ETF at the time this information is presented. Any information (which includes opinions, estimates, graphs, charts, formulae or devices) are subject to change or correction at any time without notice and are not to be relied on as advice. The information and opinions in this publication have been derived from or reached from sources believed in good faith to be reliable but have not been independently verified. LGI makes no guarantee, representation or warranty, express or implied, and accepts no responsibility or liability for the accuracy or completeness of this publication.  

You should independently assess and conduct your own investigation of the relevance, accuracy, adequacy and reliability of any information, opinion or estimates, graphs, charts, formulae or devices provided and seek professional advice on them. Any information, opinions, estimates, graphs, charts, formulae or devices provided are subject to change or correction without notice and are not to be relied on as advice. No warranty is given and no liability is accepted for any loss arising directly or indirectly as a result of you acting on such information. The ETF may, where permitted by the Prospectus, invest in financial derivative instruments for hedging or for the purposes of efficient portfolio management. The ETF’s net asset value may have higher volatility as a result of its narrower investment focus on a limited geographical market, when compared to funds investing in global or wider regional markets. LGI, its related companies, their directors and/or employees may hold units of the ETF and be engaged in purchasing or selling units of the ETF for themselves or their clients.

The units of the ETF are listed and traded on the Singapore Exchange Securities Trading Limited (“SGX-ST”), and may be traded at prices different from its net asset value, suspended from trading, or delisted. Such listing does not guarantee a liquid market for the units. You cannot purchase or redeem units in the ETF directly with the manager of the ETF, but you may, subject to specific conditions, do so on the SGX-ST or through the PDs.

©Lion Global Investors® Limited (UEN/ Registration No. 198601745D). All rights reserved. LGI is a Singapore incorporated company and is not related to any corporation or trading entity that is domiciled in Europe or the United States (other than entities owned by its holding companies).

About Lion Global Investors Limited

Lion Global Investors Limited (Co Reg No. 198601745D) is a part of Great Eastern Holdings and a member of the Oversea-Chinese Banking Corporation Limited (OCBC) Group. Established since 1986, it is a leading and one of the largest asset management companies in Southeast Asia, uniquely positioned to provide Asian equities and fixed income strategies and funds to both institutional and retail investors. As at 30 September 2023, our assets under management (AUM) stands at S$66.5 billion (US$48.8 billion). www.lionglobalinvestors.com

About Nomura Asset Management Co., Ltd. and Nomura Asset Management Singapore Limited

Nomura Asset Management group is a leading global investment management group with a wide range of innovative investment strategies including global equities, fixed income and alternatives.

The group headquarters is Nomura Asset Management Co., Ltd. in Tokyo (NAM Tokyo), with group entities in locations including Singapore, Kuala Lumpur, Hong Kong, Shanghai, Taipei, London, Frankfurt and New York, with a global workforce of over 1,400 employees.

Nomura Asset Management Singapore Limited (Co Reg No. 198800900W), a wholly-owned subsidiary of NAM Tokyo, has been operating in Singapore for the past 35 years and, among other things, acts as a marketing and client services center for Southeast Asia. https://www.nomura-am.co.jp/asia_oceania/singapore/

In relation to the Lion-Nomura Japan Active ETF (Powered by AI), Nomura Asset Management Co., Ltd (NAM Tokyo) acts as non-discretionary investment advisor to the fund. Nomura Asset Management Singapore Limited’s role is as a client service agent only.

[1] Based on AI model scores together with selection and weighting by the Manager and Investment Advisor.

 

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/lion-global-investors-launches-singapores-first-actively-managed-etf-in-collaboration-with-nomura-asset-management-302033386.html

SOURCE Lion Global Investors

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Baidu to Report First Quarter 2026 Financial Results on May 18, 2026

Published

on

By

BEIJING, April 23, 2026 /PRNewswire/ — Baidu, Inc. (Nasdaq: BIDU; HKEX: 9888 (HKD Counter) and 89888 (RMB Counter)) (“Baidu” or the “Company”), a leading AI company with strong Internet foundation, today announced that it will report its financial results for the First Quarter 2026 ended March 31, 2026, before the U.S. market opens on May 18, 2026. Baidu’s management will hold an earnings conference call at 8:00 AM on May 18, 2026, U.S. Eastern Time (8:00 PM on May 18, 2026, Beijing Time).

Please register in advance of the conference call using the link provided below. It will automatically direct you to the registration page of “Baidu Inc. Q1 2026 Earnings Conference Call”. Please follow the steps to enter your registration details, then click “Register”. Upon registering, you will then be provided with the dial-in number, the passcode, and your unique access PIN. This information will also be emailed to you as a calendar invite.

For pre-registration, please click:
https://s1.c-conf.com/diamondpass/10054331-iu876y.html

In the 10 minutes prior to the call start time, you may use the conference access information (including dial-in number(s), the passcode and unique access PIN) provided in the calendar invite that you have received following your pre-registration.

Additionally, a live and archived webcast of this conference call will be available at https://ir.baidu.com.

A replay of the conference call may be accessed by phone at the following number until May 25, 2026:
US: 1 855 883 1031
Reply PIN: 10054331

About Baidu

Founded in 2000, Baidu’s mission is to make the complicated world simpler through technology. Baidu is a leading AI company with strong Internet foundation, trading on Nasdaq under “BIDU” and the HKEX under “9888.” One Baidu ADS represents eight Class A ordinary shares.

View original content:https://www.prnewswire.com/news-releases/baidu-to-report-first-quarter-2026-financial-results-on-may-18-2026-302751204.html

SOURCE Baidu, Inc.

Continue Reading

Technology

Phase 1 of 139th Canton Fair Introduces New Dedicated Product Zones as Emerging Technologies Take Center Stage

Published

on

By

GUANGZHOU, China, April 23, 2026 /PRNewswire/ — The 139th China Import and Export Fair (Canton Fair) has further optimized its exhibition landscape with nine new dedicated product zones, reflecting ongoing structural shifts in global trade and the continued upgrading of China’s export portfolio.

Among the most closely watched additions in Phase 1 are the consumer and agricultural drone zones, both making their debut at the Canton Fair and offering a focused showcase of applications in the low‑altitude economy. The consumer drone zone showcases progress in flight control, AI‑based obstacle avoidance and energy efficiency across imaging, tourism, emergency response and patrol. The agricultural drone zone highlights precision farming, with spraying, seeding and field‑management demonstrations showing terrain‑following, intelligent route planning, and precise payload control.

On day one, a Shandong‑based drone manufacturer welcomed buyers from 30+ countries, with over 50 strong leads. One buyer, after seeing load and wind‑resistance demonstrations, immediately confirmed three sample units and even proposed becoming a regional distributor.

Display technology is another focal point of Phase 1, highlighting advances in color accuracy, energy efficiency, and overall visual performance. Developments in fine‑grained control, expanded color gamut, and reduced power consumption point to a clear trend toward immersive viewing experiences combined with sustainability gains.

The smart wearables zone underscores how intelligent devices are becoming key interfaces for human‑machine interaction. From real‑time language translation and adaptive noise cancellation to long‑term health monitoring and AI‑enabled eyewear, wearables are evolving from standalone products into integrated systems that support communication, well‑being, and productivity across daily and professional settings.

The service robots zone further illustrates how artificial intelligence is moving from conceptual exploration to large‑scale deployment. Advanced robots showcased across industrial, commercial, medical, and public‑service scenarios demonstrate growing autonomy, multi‑sensory perception, and closer human-robot collaboration.

By bringing emerging technologies into clearer focus through dedicated zones, the 139th Canton Fair is reinforcing its function as a platform where trade trends take shape, innovation meets application, and global buyers gain early insights into cutting-edge technologies.

For pre-registration, please click: https://buyer.cantonfair.org.cn/register/buyer/email?source_type=16

Photo – https://mma.prnewswire.com/media/2963958/1.jpg

View original content:https://www.prnewswire.co.uk/news-releases/phase-1-of-139th-canton-fair-introduces-new-dedicated-product-zones-as-emerging-technologies-take-center-stage-302751520.html

Continue Reading

Technology

OZMOSI Announces Strategic Partnership with Planview to Advance AI-Driven Planning in Pharmaceutical R&D

Published

on

By

By combining structured clinical intelligence with AI-driven portfolio planning, the partnership gives pharmaceutical teams a faster, clearer way to make high-stakes R&D decisions

SPRING LAKE HEIGHTS, N.J., April 23, 2026 /PRNewswire/ — OZMOSI, a leading provider of structured pharmaceutical development intelligence, today announced a strategic partnership with Planview, the leading AI-powered end-to-end platform for Strategic Portfolio Management (SPM) and Digital Product Delivery (DPD).

By integrating OZMOSI’s machine-readable clinical datasets directly into Planview’s AI-driven portfolio planning platform, external scientific data is now connected to internal R&D planning in one system,  helping pharmaceutical organizations better predict market shifts, prioritize R&D investments, and make faster, more confident decisions.

This integration brings external clinical reality into internal R&D decision-making, so teams can plan based on what’s actually happening, not just on what they hope will happen.

The two organizations combine deep expertise in complementary areas, united by a shared focus on improving the quality and usability of data for strategic decision-making. OZMOSI provides structured, machine-readable intelligence across clinical trials, drug development programs, regulatory activity, and scientific literature, built on a consistent taxonomy that standardizes how data is connected and understood. Planview’s platform enables organizations to model complex investment scenarios, align initiatives with corporate strategy, and optimize resource allocation.

Together, these capabilities give teams a clearer, more complete view of the R&D landscape, grounded in clean, standardized data and strengthened by AI-driven analysis.

“AI is only as powerful as the data that fuels it,” said Beau Bush, President and Founder of OZMOSI. “Pharmaceutical organizations have no shortage of data, but too often it’s fragmented, inconsistent, and difficult to operationalize. By bringing OZMOSI’s structured data foundation together with Planview’s AI-driven planning capabilities, we’re enabling teams to move beyond disconnected analysis and toward truly integrated, forward-looking decision-making.”

“Strategic planning in pharmaceutical R&D is becoming increasingly dependent on advanced analytics and AI,” said  Louise Allen, Chief Product Officer at Planview. “Integrating OZMOSI’s clinical intelligence into Planview’s platform enables pharmaceutical leaders to make better decisions by combining trusted external data with AI-driven planning

OZMOSI’s dataset spans more than 800,000 clinical trials, over 35,000 drugs, and 4,000 diseases and conditions. It brings together insights from clinical trial registries, regulatory filings, scientific literature, company disclosures, and industry announcements into a unified, structured dataset.

When integrated into Planview’s platform, this intelligence enables pharmaceutical and biotech organizations to evaluate competitive landscapes, identify emerging clinical trends, and simulate portfolio outcomes with unprecedented precision.

Together, OZMOSI and Planview are redefining how pharmaceutical organizations approach R&D strategy, ensuring that investment decisions are guided by accurate, standardized, and AI-ready data. By combining internal portfolio visibility with a continuously updated external view of the market, the partnership helps leaders not only understand what they have, but what to do next.

About OZMOSI

Founded in 2013, OZMOSI specializes in transforming complex pharmaceutical R&D intelligence into structured, machine-readable data. The company provides the foundation needed for accurate competitive analysis, product forecasting, and portfolio strategy. Through its proprietary taxonomy and semantic layer, OZMOSI connects fragmented data across the pharmaceutical ecosystem, enabling faster, more confident decision-making for global pharma, biotech, and investment teams.

Based in Spring Lake Heights, New Jersey, OZMOSI is focused on making pharmaceutical intelligence clear, usable, and ready for the future of AI-driven strategy. Learn more at www.ozmosi.com.

About Planview

Planview is the leading end-to-end platform for Strategic Portfolio Management (SPM) and Digital Product Delivery (DPD), powered by advanced AI capabilities that give business and technology leaders the strategic foresight to prioritize investments and initiatives, make plans real within constraints, and pivot with certainty when things change. Our AI-driven connected platform of solutions underpins the business and digital transformations of more than 3,000 customers and 3.1 million users globally. Headquartered in Austin, Texas, Planview has over 1,500 employees worldwide. Learn more at www.planview.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/ozmosi-announces-strategic-partnership-with-planview-to-advance-ai-driven-planning-in-pharmaceutical-rd-302750944.html

SOURCE Ozmosi Company

Continue Reading

Trending